Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04757181 · ClinicalTrials.gov registry record · NA
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04757181 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 38 participants.
The verdict
NCT04757181, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The goal of this study is to prospectively test the hypothesis that specific dietary modification can improve patient symptoms by promoting beneficial changes in the composition of the microbiome that, in turn, alter the immune response in such a way as to and ameliorate inflammatory conditions such as Inflammatory Bowel Disease (IBD). The potential long term benefit of this research is a validated set of efficacious dietary guidelines for persons with IBD. The potential immediate benefit to patients is symptomatic relief and healing.
Interventions
- OTHER The IBD-AID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04757181
The ClinicalTrials.gov registry entry for NCT04757181 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The IBD-AID is the first listed.
NCT04757181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04757181 about?
NCT04757181 is a clinical study titled "The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)". The goal of this study is to prospectively test the hypothesis that specific dietary modification can improve patient symptoms by promoting beneficial changes in the composition of the microbiome that, in turn, alter the immune response in such a way as to and ameliorate inflammatory conditions such...
What is the current status of trial NCT04757181?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2017-02-01. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT04757181?
The interventions under investigation include: The IBD-AID (OTHER).
Who is sponsoring clinical trial NCT04757181?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.